Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer:A Belgian expert opinion

I. Vergote; H. Denys; S. Altintas; J. Kerger; J-F. Baurain; Bours, Vincent; S. Henry; K. Van de Vijver; D. Lambrechts; Gennigens, Christine

Article (Scientific journals)

I. Vergote; H. Denys; S. Altintas et al.

2022 • In Facts, Views and Vision in Obgyn, 14 (2), p. 111-120

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/293273

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Homologous.pdf

Publisher postprint (2.16 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Epithelial ovarian cancer

Disciplines :

Oncology

Author, co-author :

I. Vergote

H. Denys

S. Altintas

J. Kerger

J-F. Baurain

Bours, Vincent ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Génétique humaine

S. Henry

K. Van de Vijver

D. Lambrechts

Gennigens, Christine ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale

Language :

English

Title :

Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer:A Belgian expert opinion

Publication date :

2022

Journal title :

Facts, Views and Vision in Obgyn

ISSN :

2032-0418

Publisher :

The Walking Egg Foundation, Wetteren, Belgium

Volume :

Issue :

Pages :

111-120

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 15 July 2022

Statistics

Number of views

45 (2 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics